You may also like
Anticoagulation Management in Severe Coronavirus Disease 2019 Patients on Extracorporeal Membrane Oxygenation
Hypercoagulability and secondary hyperfibrinolysis during ECMO support in COVID-19 patients are common and possibly increase the propensity for thrombotic events and failure of the oxygenator. Currently, there is not enough evidence to support a more aggressive anticoagulation strategy.
1 min read
Reversal of Heparin After Cardiac Surgery: Protamine Titration Using a Statistical Model
The objective of this study is to establish a statistical model for determination of protamine dose in conjunction with cardiopulmonary bypass.
1 min read
How to Reduce Mortality in ST-Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Interventions: Cut the Bleeding
The primary purpose of this analysis is to evaluate the hypothesis that the reduction of in-hospital bleeding is the most plausible explanation for the improved survival of STEMI patients treated with bivalirudin during primary PCI.
1 min read
